189 results on '"Wee Joseph"'
Search Results
2. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma
3. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
4. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
5. Self‐Degrading Molecular Organogels: Self‐Assembled Gels Programmed to Spontaneously Liquefy after a Set Time.
6. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
7. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
8. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
9. High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade
10. A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma
11. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
12. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer – A prospective cohort analysis
13. P206 / #618 - AN INITIAL EXPERIENCE WITH PROTON PLAN ADAPTATION FOR HEAD AND NECK CANCERS
14. O060 / #409 - PROSPECTIVE EVALUATION OF ACUTE TOXICITY DURING IMPT FOR HEAD AND NECK MALIGNANCIES IN NATIONAL CANCER CENTRE SINGAPORE (NCCS)
15. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors
16. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines
17. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
18. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma
19. Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma
20. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials
21. Nasopharyngeal carcinoma
22. Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
23. Global diversity, population stratification, and selection of human copy-number variation
24. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
25. Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC
26. Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients
27. Dr. PA Shah Oration 2022.
28. Quality-of-Life-Adjusted Survival Analysis of Concurrent Chemo Radiotherapy for Locally Advanced (Nonmetastatic) Nasopharyngeal Cancer
29. HUMAN GENOMICS: Global diversity, population stratification, and selection of human copy-number variation
30. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis
31. Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore Experience
32. Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index
33. The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients
34. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
35. Can external and subjective information ever be used to reduce the size of randomised controlled trials?
36. Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma
37. Vocal Fold Paralysis Following Radiotherapy for Nasopharyngeal Carcinoma: Laryngeal Electromyography Findings
38. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires
39. RETROPHARYNGEAL NODAL METASTASIS RELATED TO HIGHER RATE OF DISTANT METASTASIS IN PATIENTS WITH N0 AND N1 NASOPHARYNGEAL CANCER
40. Triplet Combination of Gemcitabine, Paclitaxel, and Carboplatin Followed by Maintenance 5-Fluorouracil and Folinic Acid in Patients With Metastatic Nasopharyngeal Carcinoma
41. Genomic insights into the peopling of the Southwest Pacific
42. Genomic analyses inform on migration events during the peopling of Eurasia
43. The Simons Genome Diversity Project: 300 genomes from 142 diverse populations
44. Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580
45. Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
46. Variability and Sample Size Requirements for Health-Related Quality-of-Life Measures: Understanding the Challenges Facing Investigators
47. Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
48. Variability and Sample Size Requirements of Quality-of-Life Measures: A Randomized Study of Three Major Questionnaires
49. Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A Phase II trial using a triplet combination
50. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.